PD-L1 and Tumor Infiltrating Lymphocytes as Prognostic Markers in Resected NSCLC
Malaka Ameratunga, Khashayar Asadi, Xihui Lin, Marzena Walkiewicz, Carmel Murone, Simon Knight, Paul Mitchell, Paul Boutros, Thomas John
PLOS ONE | PUBLIC LIBRARY SCIENCE | Published : 2016
Thomas John received funding from the National Health and Medical Research Council (NHMRC). This study was conducted with the support of the Ontario Institute for Cancer Research to PCB through funding provided by the Government of Ontario. Dr. Boutros was supported by a Terry Fox Research Institute New Investigator Award and by a Canadian Institutes of Health Research (CIHR) New Investigator Award. The Victorian Cancer Biobank is supported by the Victorian Government. Assoc Prof John is an NHMRC Early Career Scholar and receives funding from the Cancer Council Victoria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.